RXRX- Recursion Pharmaceuticals, Inc.

Name: Recursion Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 3 buys and 15 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Borgeson Blake	6.65M	$20.95M	-
Dir	Gibson Christopher	4.52M	$14.25M	-
CEO	Khan Najat	2.26M	$7.13M	-
Dir	Li Dean Y	1.24M	$3.91M	-
Other	Hallett David	1.11M	$3.49M	-

Activity

Buys and sells only

Transactions

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 18, 2023	Borgeson Blake69	Director	Sell	8,885	$5.93	$52,729.81	-0.1%	+125.7%	+25.8%
Apr 6, 2023	Gibson Christopher70	Chief Executive Officer	Sale+OE	53,327	$6.60	$351,709.78	-2.8%	+9.6%	+33.4%
Apr 4, 2023	Borgeson Blake69	Director	Sell	8,885	$6.53	$57,991.51	-0.1%	+12.3%	+35.9%
Mar 21, 2023	Borgeson Blake69	Director	Sell	8,885	$7.40	$65,743.67	-0.1%	+20.9%	+49.0%
Mar 9, 2023	Gibson Christopher70	Chief Executive Officer	Sale+OE	110,890	$8.05	$892,894.24	-5.5%	+20.9%	+49.2%
Mar 7, 2023	Borgeson Blake69	Director	Sell	8,885	$8.33	$73,988.95	-0.1%	+2.2%	+37.2%
Mar 2, 2023	Gibson Christopher70	Chief Executive Officer	Sell	21,000	$7.92	$166,268.05	-2.2%	+9.5%	+59.9%
Mar 2, 2023	Mubadala Investment Co Pjsc62	10% Owner	Buy	66,822	$7.82	$522,354.26	+0.5%	+9.5%	+59.9%
Mar 1, 2023	Mubadala Investment Co Pjsc62	10% Owner	Buy	48,867	$7.94	$388,082.17	+0.4%	+10.9%	+69.3%
Feb 28, 2023	Mubadala Investment Co Pjsc62	10% Owner	Buy	815	$7.97	$6,495.55	-	+8.2%	+58.8%

← PrevPage 14Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC